JP2024539106A5 - - Google Patents
Info
- Publication number
- JP2024539106A5 JP2024539106A5 JP2024523484A JP2024523484A JP2024539106A5 JP 2024539106 A5 JP2024539106 A5 JP 2024539106A5 JP 2024523484 A JP2024523484 A JP 2024523484A JP 2024523484 A JP2024523484 A JP 2024523484A JP 2024539106 A5 JP2024539106 A5 JP 2024539106A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- formula
- compound
- salt form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163262732P | 2021-10-19 | 2021-10-19 | |
| US63/262,732 | 2021-10-19 | ||
| PCT/US2022/078177 WO2023069880A1 (en) | 2021-10-19 | 2022-10-14 | Novel methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539106A JP2024539106A (ja) | 2024-10-28 |
| JP2024539106A5 true JP2024539106A5 (https=) | 2025-10-20 |
Family
ID=86058575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523484A Pending JP2024539106A (ja) | 2021-10-19 | 2022-10-14 | 新規方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240415832A1 (https=) |
| EP (1) | EP4419523A4 (https=) |
| JP (1) | JP2024539106A (https=) |
| KR (1) | KR20240089771A (https=) |
| CN (1) | CN118556058A (https=) |
| AU (1) | AU2022368858A1 (https=) |
| CA (1) | CA3235356A1 (https=) |
| IL (1) | IL312165A (https=) |
| MX (1) | MX2024004725A (https=) |
| WO (1) | WO2023069880A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7520013B2 (ja) | 2018-12-17 | 2024-07-22 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 置換複素環縮合γ－カルボリンの合成 |
| IL315005B2 (en) | 2018-12-17 | 2026-04-01 | Intra Cellular Therapies Inc | Synthesis of condensed gamma-carbolines and converted heterocycles |
| JP7649743B2 (ja) | 2018-12-21 | 2025-03-21 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| EP4680244A1 (en) | 2023-03-17 | 2026-01-21 | Norwegian University Of Life Sciences | Serotonin 5ht2a receptor antagonist for use in treating side effects resulting form mu opioid receptor agonist overdose |
| WO2026011136A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2026011166A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Substituted heterocycles for use in the treatment of diseases involving the 5-ht2a receptor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019023062A1 (en) * | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
| EP3833346A4 (en) * | 2018-08-08 | 2022-08-03 | Torralva Medical Therapeutics LLC | Compositions for opiate and opioid prevention and reversal, and methods of their use |
| JP7649743B2 (ja) * | 2018-12-21 | 2025-03-21 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| CN118105390A (zh) * | 2019-01-23 | 2024-05-31 | 细胞内治疗公司 | 治疗成瘾的方法 |
| JP7397095B2 (ja) * | 2019-05-07 | 2023-12-12 | ニーサム・ラボラトリーズ・インコーポレイテッド | オピオイド受容体アンタゴニストプロドラッグ |
| JP2025509569A (ja) * | 2022-03-14 | 2025-04-11 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
-
2022
- 2022-10-14 MX MX2024004725A patent/MX2024004725A/es unknown
- 2022-10-14 IL IL312165A patent/IL312165A/en unknown
- 2022-10-14 KR KR1020247016018A patent/KR20240089771A/ko active Pending
- 2022-10-14 CN CN202280084050.5A patent/CN118556058A/zh active Pending
- 2022-10-14 JP JP2024523484A patent/JP2024539106A/ja active Pending
- 2022-10-14 AU AU2022368858A patent/AU2022368858A1/en active Pending
- 2022-10-14 EP EP22884603.6A patent/EP4419523A4/en active Pending
- 2022-10-14 WO PCT/US2022/078177 patent/WO2023069880A1/en not_active Ceased
- 2022-10-14 CA CA3235356A patent/CA3235356A1/en active Pending
- 2022-10-14 US US18/703,145 patent/US20240415832A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024539106A5 (https=) | ||
| TWI844786B (zh) | 一種藥物組合物及其應用 | |
| US6482838B2 (en) | Methods for treating cognitive impairments caused by traumatic brain injuries | |
| AU2014206036B2 (en) | Fluorinated CBD compounds, compositions and uses thereof | |
| JP6382416B2 (ja) | 疾患の治療方法 | |
| JPS5995269A (ja) | 抗てんかん性医薬品 | |
| JP2009541484A (ja) | ５ｈｔ６モジュレーターおよびコリンエステラーゼインヒビターを含む組み合わせ | |
| AU2021217130A1 (en) | Method for treating coronavirus infections | |
| IL312165A (en) | New methods | |
| JP2016512818A (ja) | テトランドリンファミリーの医薬製剤及び方法 | |
| JP2005532397A5 (https=) | ||
| JPH02502185A (ja) | 咳および気管支収縮の治療用５‐ｈｔ３レセプター拮抗物質 | |
| EA006742B1 (ru) | КОМПОЗИЦИИ ДЛЯ ИНГАЛЯЦИИ, СОДЕРЖАЩИЕ ТРИЦИКЛИЧЕСКИЕ 5,6-ДИГИДРО-9H-ПИРАЗОЛО(3,4-c)-1,2,4-ТРИАЗОЛО (4,3-α) ПИРИДИНЫ | |
| WO2014210369A2 (en) | Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents | |
| JPH0269417A (ja) | 精神分裂病治療用組成物 | |
| JP2020520374A (ja) | 関節リウマチの治療用組成物および治療方法 | |
| KR102267754B1 (ko) | 정맥내 항바이러스 치료 | |
| US20090163544A1 (en) | Use of NK-3 Receptor Antagonists for the Treatment of Nausea and Vomiting | |
| JP2009538822A5 (https=) | ||
| AU2016216578B2 (en) | The use of amisulpride as an anti-emetic | |
| KR20220099435A (ko) | ＳＡＲＳ-ＣｏＶ-2 감염증 치료 또는 예방용 약학 조성물 | |
| RU2005126459A (ru) | Производные диазепана, используемые в качестве ингибиторов lfa | |
| HK40063844B (zh) | 一种药物组合物及其应用 | |
| WO2009104152A1 (en) | Combination treatment for ovarian cancer | |
| JP2008156241A (ja) | 体重減少薬 |